Length of postoperative hospital stay · Children having heart surgery with cardiopulmonary bypass
1 finding from 1 review
Mortality within the longest · Children having heart surgery with cardiopulmonary bypass
Glucocorticoid showed no clear difference in all‐cause mortality at longest compared with placebo (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · Children having heart surgery with cardiopulmonary bypass
Glucocorticoid showed no clear difference in cardiovascular mortality at longest compared with placebo (moderate certainty).
1 finding from 1 review
Failure to separate from CPB · Children having heart surgery with cardiopulmonary bypass
Glucocorticoid showed no clear difference in failure to separate from CPB compared with placebo (low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality: up to 3 months' · participants with alcoholic hepatitis at high risk of mortality and morbidity
It is very uncertain whether the intervention changes all‐cause mortality: up to 3 months' (very low certainty).
1 finding from 1 review
Intervention not reported
Health‐related quality of life: up to 3 months ( · participants with alcoholic hepatitis at high risk of mortality and morbidity
The intervention showed no clear difference in health‐related quality of life: up to 3 months ( (low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events during treatment · participants with alcoholic hepatitis at high risk of mortality and morbidity
It is very uncertain whether the intervention changes serious adverse events during treatment (very low certainty).
1 finding from 1 review
Intervention not reported
Liver‐related mortality: up to 3 months' · participants with alcoholic hepatitis at high risk of mortality and morbidity
It is very uncertain whether the intervention changes liver‐related mortality: up to 3 months' (very low certainty).
1 finding from 1 review
Intervention not reported
Participants with any complication: up to 3 months following randomisation · participants with alcoholic hepatitis at high risk of mortality and morbidity
It is very uncertain whether the intervention changes participants with any complication: up to 3 months following… (very low certainty).
1 finding from 1 review
Intervention not reported
Participants with non‐serious adverse events: up to 3 months' · participants with alcoholic hepatitis at high risk of mortality and morbidity
It is very uncertain whether the intervention changes participants with non‐serious adverse events: up to 3 months' (very low certainty).
1 finding from 1 review
Linear growth velocity (cm/year) · children up to 18 years of age with persistent asthma
Effects of different delivery devices on growth in children with… showed no clear difference in linear growth velocity (cm/year) compared with chlorofluorocarbon‐metered dose inhaler beclomethasone (low certainty).
1 finding from 1 review
Change in height · children up to 18 years of age with persistent asthma
Effects of different delivery devices on growth in children with… may leads to higher change in height (cm) over a period of time compared with turbuhaler‐budesonide (low certainty).
1 finding from 1 review
All‐cause mortality Up to 28 days following admission · individuals with influenza
It is very uncertain whether corticosteroid therapy changes number of deaths at 30 days following admission (30‐day mortality)a compared with no corticosteroid therapy (very low certainty).
1 finding from 1 review
Incidence of admissions to the ICU · individuals with influenza
It is very uncertain whether corticosteroid therapy changes rate of admission to intensive care units compared with no corticosteroid therapy (very low certainty).
1 finding from 1 review
Number and nature of adverse events secondary to corticosteroid use (hospital‐acquired infection) · individuals with influenza
It is very uncertain whether corticosteroid therapy changes number and nature of adverse events secondary to corticosteroid use… compared with no corticosteroid therapy (very low certainty).
1 finding from 1 review
Incidence of mechanical ventilation · individuals with influenza
It is very uncertain whether corticosteroid therapy changes proportion of participants requiring mechanical ventilation compared with no corticosteroid therapy (very low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality six months after Kasai portoenterostomy · infants with biliary atresia
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Serious adverse event, two years · infants with biliary atresia
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Health‐related quality of life · infants with biliary atresia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Infants who did not clear jaundice at six months · infants with biliary atresia
1 finding from 1 review
no estimate extracted
Studies not reported
Low